Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HBM Healthcare InvestmentsHBMBF 30 Debt-to-Equity is 0.05 as of Mar. 2026, which is 29% below its 10-year median of 0.07. GuruFocus rates HBMBF with a GF Score™ of 30/100. The stock has 6 warning signs investors should review. Among 960 Asset Management companies, HBM Healthcare Investments ranks better than 81.25% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for HBM Healthcare Investments's Debt-to-Equity or its related term are showing as below:
HBMBF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05 Med: 0.07 Max: 0.09
Current: 0.05
During the past 13 years, the highest Debt-to-Equity Ratio of HBM Healthcare Investments was 0.09. The lowest was 0.05. And the median was 0.07.
HBMBF's Debt-to-Equity is ranked better than 81.25% of 960
companies
in the Asset Management industry
Industry Median: 0.21
vs HBMBF: 0.05
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
HBM Healthcare Investments Debt-to-Equity Related Terms
HBM Healthcare Investments Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, HBM Healthcare Investments's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HBM Healthcare Investments Debt-to-Equity vs Asset Management Industry
For the Asset Management industry and Financial Services sector, HBM Healthcare Investments's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where HBM Healthcare Investments's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HBM Healthcare Investments (HBMBF) has a Debt-to-Equity of 0.05 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on HBM Healthcare Investments and its competitors. This is 29% below median its historical median of 0.07. Over the past decade, HBM Healthcare Investments' Debt-to-Equity has ranged from 0.05 to 0.09. According to the industry distribution chart, HBM Healthcare Investments ranks #180 out of 960 companies in the Asset Management industry, placing it in the top 18.7%.
Is HBM Healthcare Investments' Debt-to-Equity too high?
HBM Healthcare Investments' current Debt-to-Equity of 0.05 is 29% below median its 10-year median of 0.07. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.09. The Asset Management industry median Debt-to-Equity is 0.21. HBM Healthcare Investments' value of 0.05 is 76.2% below this industry median. Based on the distribution chart, HBM Healthcare Investments ranks #180 out of 960 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, HBM Healthcare Investments has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' Debt-to-Equity compare to BLK and BX?
According to the Asset Management industry distribution chart, HBM Healthcare Investments ranks #180 out of 960 companies for Debt-to-Equity. This places HBM Healthcare Investments in the top 19% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.21. HBM Healthcare Investments' value of 0.05 is 76.2% below this benchmark. Historically, HBM Healthcare Investments' own Debt-to-Equity has ranged from 0.05 to 0.09 over the past decade. While the company's 10-year median is 0.07 vs. the industry median of 0.21, HBM Healthcare Investments has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Asset Management company?
The median Debt-to-Equity among Asset Management companies is 0.21, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HBM Healthcare Investments's current Debt-to-Equity of 0.05 is 76.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on HBM Healthcare Investments and its competitors. For the Asset Management industry, the median Debt-to-Equity is 0.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HBM Healthcare Investments's current Debt-to-Equity is 0.05, which is 29% below median its own 10-year median of 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (HBMBF) has a current Debt-to-Equity of 0.05. The current Debt-to-Equity is 0.05, which is 29% below median its 10-year median of 0.07 and 76.2% below the Asset Management industry median of 0.21. HBM Healthcare Investments' overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For HBM Healthcare Investments (HBMBF), the current Debt-to-Equity is 0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
30GF Score
Get the complete analysis for HBMBF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HBMBF has been successfully added to your 
